The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2017

Filed:

Jul. 08, 2013
Applicant:

Institut Gustave-roussy, Villejuif, FR;

Inventors:

Jean-Luc Perfettini, Meaux, FR;

Guido Kroemer, Paris, FR;

Eric Deutsch, Paris, FR;

Assignee:

Institut Gustave-Roussy, Villejuif, FR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); G01N 33/50 (2006.01); C12Q 1/68 (2006.01); G01N 33/574 (2006.01); C12N 15/113 (2010.01); G01N 33/566 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5011 (2013.01); C12N 15/113 (2013.01); C12N 15/1135 (2013.01); C12Q 1/6881 (2013.01); C12Q 1/6886 (2013.01); G01N 33/566 (2013.01); G01N 33/574 (2013.01); G01N 33/57496 (2013.01); G01N 33/6872 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present inventors show that cannibal cells can undergo senescence after entosis in vivo and that the tumor suppressive protein p53 act as a repressor of this phenomenon. They therefore propose new tools to study the molecular pathways involved in the cannibalism process, for example by measuring the expression levels of p53 or splice variants thereof (such as Δ133TP53, TP53β, TP53γ or Δ40TP53), the release of extracellular ATP or purinergic P2Y2 receptor activity. The present inventors also demonstrated that the detection of senescent cannibal cells in breast adenocarcinoma obtained from patients treated with neo-adjuvant therapy positively correlates with good patient's response to treatment. Altogether, these results provide the first evidence that detection of cellular cannibalism and senescence simultaneously in tumors helps for the diagnosis of disease outcomes and for the prediction of treatment efficiency against cancer diseases.


Find Patent Forward Citations

Loading…